Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001662002-17-000001
Filing Date
2017-11-16
Accepted
2017-11-16 14:16:24
Documents
1
Effectiveness Date
2017-11-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8425
  Complete submission text file 0001662002-17-000001.txt   9501
Mailing Address 1616 EASTLAKE AVENUE EAST SUITE 202 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVENUE EAST SUITE 202 SEATTLE WA 98102 61430589444
Nohla Therapeutics Inc. (Filer) CIK: 0001662002 (see all company filings)

EIN.: 475261773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-275626 | Film No.: 171207699